Advanced HCC — RACP Adult Medicine MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: D — Sorafenib
Advanced HCC (BCLC stage C: vascular invasion and/or extrahepatic spread) with preserved performance status is managed with systemic therapy. First-line treatment is now atezolizumab + bevacizumab (IMbrave150 trial). Sorafenib (or lenvatinib) is used if immunotherapy is contraindicated. Transplant and resection are not appropriate for advanced disease.
Reference: Cancer Council Australia – 2024 – HCC; AASLD 2023